VIR Earnings
Latest Revenue238.9M
Latest Net Income80.1M
| Period | EPS | Revenue | Net Income | Rev YoY | EPS YoY |
|---|
| Q2 2026 | $0.48 | 238.9M | 80.1M | +19,582.5% | +160.0% |
| Q1 2026 | -$0.85 | -29000 | -125695000 | -101.0% | +3.4% |
| Q4 2025 | -$0.31 | 64.1M | -42923000 | +417.8% | +59.2% |
| Q3 2025 | -$1.17 | 240.0K | -163141000 | -89.9% | +25.0% |
| Q2 2025 | -$0.80 | 1.2M | -110958000 | -60.5% | +21.6% |
| Q1 2025 | -$0.88 | 3.0M | -120965000 | -94.6% | -83.3% |
| Q4 2024 | -$0.76 | 12.4M | -104589000 | -26.3% | +11.6% |
| Q3 2024 | -$1.56 | 2.4M | -213717000 | -9.8% | -27.9% |
| Q2 2024 | -$1.02 | 3.1M | -138378000 | — | — |
| Q1 2024 | -$0.48 | 56.4M | -65276000 | — | — |
| Q4 2023 | -$0.86 | 16.8M | -115973000 | — | — |
| Q3 2023 | -$1.22 | 2.6M | -163413000 | — | — |
Vir Biotechnology (VIR) — Earnings